Detalhe da pesquisa
1.
Sample size re-estimation in Phase 2 dose-finding: Conditional power versus Bayesian predictive power.
Pharm Stat
; 22(2): 349-364, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36418025
2.
Empirical profile Bayesian estimation for extrapolation of historical adult data to pediatric drug development.
Pharm Stat
; 19(6): 787-802, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32573051
3.
Once- versus twice-daily dosing of eliglustat in adults with Gaucher disease type 1: The Phase 3, randomized, double-blind EDGE trial.
Mol Genet Metab
; 123(3): 347-356, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29358012
4.
Determination of rifabutin dosing regimen when administered in combination with ritonavir-boosted atazanavir.
J Antimicrob Chemother
; 66(9): 2075-82, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21712242
5.
miR-143-3p targeting of ITGA6 suppresses tumour growth and angiogenesis by downregulating PLGF expression via the PI3K/AKT pathway in gallbladder carcinoma.
Cell Death Dis
; 9(2): 182, 2018 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29416013
6.
MicroRNA-133a-3p exerts inhibitory effects on gallbladder carcinoma via targeting RBPJ.
Am J Cancer Res
; 6(11): 2448-2462, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27904763
7.
A novel PI3K/AKT signaling axis mediates Nectin-4-induced gallbladder cancer cell proliferation, metastasis and tumor growth.
Cancer Lett
; 375(1): 179-189, 2016 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26949052
8.
Effects of the H2-receptor antagonist famotidine on the pharmacokinetics of atazanavir-ritonavir with or without tenofovir in HIV-infected patients.
AIDS Patient Care STDS
; 25(9): 509-15, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21770762